Phase 1b/ 2 Study of a Radio-Enhancer, PEP503 (NBTXR3), in Combination with Concurrent Chemo-Radiation in Locally Advanced or Unresectable Rectal Cancer.
JOURNAL OF CLINICAL ONCOLOGY(2022)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined